Nascent Biotech, Inc. (OTCMKTS:NBIO – Get Free Report)’s share price crossed below its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of $0.06 and traded as low as $0.05. Nascent Biotech shares last traded at $0.05, with a volume of 94,600 shares traded.
Nascent Biotech Price Performance
The company has a 50-day moving average price of $0.06 and a two-hundred day moving average price of $0.06.
About Nascent Biotech
Nascent Biotech, Inc, a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of various forms of cancer. It is developing Pritumumab, a drug to treat patients with brain cancer malignancies, such as glioblastoma and malignant astrocytoma, as well as epithelial cancers, including lung, breast, colon, brain, and pancreas cancer.
Featured Articles
- Five stocks we like better than Nascent Biotech
- EV Stocks and How to Profit from Them
- Work and Play: Investing in the Rise of Bleisure Travel
- How to Invest in Small Cap Stocks
- Top Dividend Stocks to Buy Now as Bond Yields Could Lower
- How to Read Stock Charts for Beginners
- SAP: AI Tailwinds Accelerating Enterprise Cloud Business
Receive News & Ratings for Nascent Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nascent Biotech and related companies with MarketBeat.com's FREE daily email newsletter.
